Reoperative Maxillofacial Oncology

Daniel Petrisor; Rui Fernandes

doi:10.1016/j.coms.2010.11.002

Reoperative Maxillofacial Oncology

Daniel Petrisor, Rui Fernandes

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Approximately 36,000 people in the United States will be diagnosed with oral or oropharyngeal cancer in 2010. In more than 90% of the cases of oral cavity and oropharyngeal cancers, histopathologic examination reveals squamous cell carcinoma (SCCA). Despite appropriate initial treatment, oral SCCA recurs in 25% to 48% of cases. Several studies have shown that most cancers recur within about 2 years after the initial treatment. Hence, close follow-up of patients is important for the timely detection of recurrences. This article discusses the types of recurrence and the surveillance and treatment of recurrent oral SCCA.

Original language	English (US)
Pages (from-to)	161-168
Number of pages	8
Journal	Oral and Maxillofacial Surgery Clinics of North America
Volume	23
Issue number	1
DOIs	https://doi.org/10.1016/j.coms.2010.11.002
State	Published - Feb 2011
Externally published	Yes

Keywords

Locoregional
Oropharyngeal
Radiotherapy
Recurrence

ASJC Scopus subject areas

Surgery
Oral Surgery
Otorhinolaryngology

Access to Document

10.1016/j.coms.2010.11.002

Cite this

@article{f8dee8f2cf0e45c9b4b7785114338fb9,

title = "Reoperative Maxillofacial Oncology",

abstract = "Approximately 36,000 people in the United States will be diagnosed with oral or oropharyngeal cancer in 2010. In more than 90% of the cases of oral cavity and oropharyngeal cancers, histopathologic examination reveals squamous cell carcinoma (SCCA). Despite appropriate initial treatment, oral SCCA recurs in 25% to 48% of cases. Several studies have shown that most cancers recur within about 2 years after the initial treatment. Hence, close follow-up of patients is important for the timely detection of recurrences. This article discusses the types of recurrence and the surveillance and treatment of recurrent oral SCCA.",

keywords = "Locoregional, Oropharyngeal, Radiotherapy, Recurrence",

author = "Daniel Petrisor and Rui Fernandes",

year = "2011",

month = feb,

doi = "10.1016/j.coms.2010.11.002",

language = "English (US)",

volume = "23",

pages = "161--168",

journal = "Oral and Maxillofacial Surgery Clinics of North America",

issn = "1042-3699",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Reoperative Maxillofacial Oncology

AU - Petrisor, Daniel

AU - Fernandes, Rui

PY - 2011/2

Y1 - 2011/2

N2 - Approximately 36,000 people in the United States will be diagnosed with oral or oropharyngeal cancer in 2010. In more than 90% of the cases of oral cavity and oropharyngeal cancers, histopathologic examination reveals squamous cell carcinoma (SCCA). Despite appropriate initial treatment, oral SCCA recurs in 25% to 48% of cases. Several studies have shown that most cancers recur within about 2 years after the initial treatment. Hence, close follow-up of patients is important for the timely detection of recurrences. This article discusses the types of recurrence and the surveillance and treatment of recurrent oral SCCA.

AB - Approximately 36,000 people in the United States will be diagnosed with oral or oropharyngeal cancer in 2010. In more than 90% of the cases of oral cavity and oropharyngeal cancers, histopathologic examination reveals squamous cell carcinoma (SCCA). Despite appropriate initial treatment, oral SCCA recurs in 25% to 48% of cases. Several studies have shown that most cancers recur within about 2 years after the initial treatment. Hence, close follow-up of patients is important for the timely detection of recurrences. This article discusses the types of recurrence and the surveillance and treatment of recurrent oral SCCA.

KW - Locoregional

KW - Oropharyngeal

KW - Radiotherapy

KW - Recurrence

UR - http://www.scopus.com/inward/record.url?scp=78751690312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751690312&partnerID=8YFLogxK

U2 - 10.1016/j.coms.2010.11.002

DO - 10.1016/j.coms.2010.11.002

M3 - Review article

C2 - 21272772

AN - SCOPUS:78751690312

SN - 1042-3699

VL - 23

SP - 161

EP - 168

JO - Oral and Maxillofacial Surgery Clinics of North America

JF - Oral and Maxillofacial Surgery Clinics of North America

IS - 1

ER -

Reoperative Maxillofacial Oncology

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this